CLINICAL_TRIALS
trial_result
· 2013-03-22
Clinical Trial Update: Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes [Phase 3]
Summary
Phase 3 clinical trial update reporting efficacy and safety data for alogliptin in adults with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-03-22